Stock data

全宇生技-KY (4148)

全宇生技-KY is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$367.35M, up 5.3% from a year earlier. EPS over the last four quarters totals NT$2.73.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 全宇生技-KY in Insightr